Skip to main content

Navigation group

Type at least 3 characters
4,316 articles

Articles

Original Research

Published on 16 Jul 2024

Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience

in Antimicrobials, Resistance and Chemotherapy

  • Cristiana Leanza
  • Maria Teresa Mascellino
  • Lorenzo Volpicelli
  • Sara Covino
  • Antonio Falletta
  • Francesca Cancelli
  • Cristiana Franchi
  • Martina Carnevalini
  • Claudio M. Mastroianni
  • Alessandra Oliva
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience
Frontiers in Microbiology
doi 10.3389/fmicb.2024.1432296
  • 1,731 views
  • 1 citation